In our study, we provide novel evidence that a subset of oncogenic K-Ras mutants (G13D and G12V) can attenuate LKB1/AMPK signaling in colon carcinoma cells, whereas G12D cannot. The gene discussed is PRKAA2; the disease is colon carcinoma.